Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Allergic Rhinitis - Pipeline Review, H2 2016 - Key Vendors Are 3M Drug Delivery Systems, Allergy Therapeutics & GlaxoSmithKline - Research and Markets

Research and Markets
Posted on: 27 Oct 16

Research and Markets has announced the addition of the "Allergic Rhinitis - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Rhinitis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • 3M Drug Delivery Systems
  • Accolade Pharmaceuticals, LLC
  • AFFiRiS AG
  • ALK-Abello A/S
  • Allergy Therapeutics Plc
  • Ampio Pharmaceuticals, Inc.
  • Array BioPharma Inc.
  • ASIT biotech s.a.
  • Axikin Pharmaceuticals, Inc.
  • Chong Kun Dang Pharmaceutical Corp.
  • Chrysalis BioTherapeutics, Inc.
  • ELORAC, Inc.
  • Faes Farma, S.A.
  • Fountain Biopharma Inc.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • HAL Allergy BV
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Laboratorios LETI S.L.
  • (15+ Others)

Key Topics Covered:

  1. Introduction
  2. Allergic Rhinitis Overview
  3. Therapeutics Development
  4. Pipeline Products for Allergic Rhinitis - Overview
  5. Pipeline Products for Allergic Rhinitis - Comparative Analysis
  6. Allergic Rhinitis - Therapeutics under Development by Companies
  7. Allergic Rhinitis - Therapeutics under Investigation by Universities/Institutes
  8. Allergic Rhinitis - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Allergic Rhinitis - Products under Development by Companies
  13. Allergic Rhinitis - Products under Investigation by Universities/Institutes
  14. Allergic Rhinitis - Companies Involved in Therapeutics Development

For more information about this report visit

View source version on

Business Wire

Last updated on: 27/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.